Amyloidosis Alliance The Voice of Patients

Research

Clinical trials

Every amyloidosis study now recruiting, about to open, or enrolling by invitation, anywhere in the world, listed straight from ClinicalTrials.gov and refreshed every day.

Information, not medical advice. The Alliance does not run these studies and cannot enrol you in one. If a trial looks relevant, discuss it with the doctor who follows your amyloidosis.

Recruiting and upcoming studies

The list covers AL, ATTR and AA amyloidosis as well as cerebral amyloid angiopathy. Each card says where the study stands: open to anyone who meets its criteria, not yet open, or restricted to people the investigators invite. Studies that close simply leave the list.

Showing 109–120 of 202 trials

RecruitingNot specified

Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load (opens on ClinicalTrials.gov)

Background: Anakinra is a drug used to treat people with certain diseases that affect their immune systems. Sometimes anakinra can cause proteins under the…

Study
Interventional (treatment)
Phase
Phase 1
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting in: United States

NCT06974877Updated 19 May 2026

RecruitingAL (light chain)

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion (opens on ClinicalTrials.gov)

Immunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis. AL amyloidosis has many root causes and is characterized by the…

Study
Interventional (treatment)
Phase
Phase 1
Sponsor
AbbVie

Recruiting in: AustraliaFranceGreeceItaly+2

NCT06158854Updated 13 May 2026

RecruitingAL (light chain)

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients (opens on ClinicalTrials.gov)

This study is a clinical trial aimed at the marketing of TQB2934 for injection. The project plans to enroll 70 subjects, including 13-21 subjects…

Study
Interventional (treatment)
Phase
Phase 1
Sponsor
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Recruiting in: China

NCT07266116Updated 8 May 2026

RecruitingAL (light chain)

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis (opens on ClinicalTrials.gov)

This phase III trial compares the effect of adding a stem cell transplant with melphalan after completing chemotherapy with daratumumab, cyclophosphamide, bortezomib and dexamethasone…

Study
Interventional (treatment)
Phase
Phase 3
Sponsor
SWOG Cancer Research Network

Recruiting in: United States

NCT06022939Updated 6 May 2026

RecruitingAL (light chain)

A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA) (opens on ClinicalTrials.gov)

A prospective patients' registry collecting all new cases of AL amyloidosis evaluated at referral Centers from across Europe and a sample sharing network will…

Study
Observational (registry, imaging)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia

Recruiting in: GermanyItalyNetherlandsSpain+2

NCT06205953Updated 16 April 2026

This list only covers amyloidosis studies that are open or about to open. The registry holds every study, including those already completed.

Search all studies on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov (U.S. National Library of Medicine). List last retrieved on 7 November 2026. clinicaltrials.gov

Not sure where to start?

Our member associations know the teams running these studies in their own country, and can help you prepare the conversation with your doctor.

Find an association near you
Contact the Alliance